作者: M. Takemoto , M. Kuroda , M. Urano , Y. Nishimura , S. Kawasaki
DOI: 10.1080/0265673021000035235
关键词: Melphalan 、 Cisplatin 、 Pathology 、 Cyclophosphamide 、 Chemotherapy 、 Medicine 、 Chemosensitizing agent 、 Ifosfamide 、 Cancer research 、 Mitomycin C 、 Hyperthermia
摘要: It has been shown that hyperthermia can enhance the cytotoxicity of some chemotherapeutics. However, most effective agent(s) at elevated temperatures have yet to be determined. A previous study suggests drug choice may different from physiological temperature, and alkylating agents temperatures. To further investigate these possibilities, effect chemotherapeutic were compared. These cyclophosphamide, ifosfamide, melphalan, cis-diamminedichloroplatinum (II), 5-fluorouracil, mitomycin C bleomycin. Three tumours (mammary carcinoma, osteosarcoma squamous cell carcinoma) used. They transplanted into feet C3H/He mice. When reached 65 mm(3), a test agent was injected intraperitoneally. Tumours immediately heated 41.5 degrees for 30 min, tumour growth (TG) time studied each tumour. Using TG times, TG-50 (the required one-half total number treated reach volume 800 mm(3) mm(3)) calculated. Subsequently, delay (GDT) thermal enhancement ratio (TER) obtained. The GDT difference between non-treated control tumours. TER group with an room temperature. Results showed top three tested solely agents--CY, IFO L-PAM--for kind cisplatin smaller than those agents. smallest TER, 1.1, observed which given mammary C, carcinoma. could concluded might drugs many types possible mechanisms associated are discussed.